Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02683850 · ClinicalTrials.gov registry record · Early Phase 1
Influence of an Omega-3 SPM Supplement on Quality of Life
A Early Phase 1 study, sponsored by National University of Natural Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 44
- Enrollment target
NCT02683850: Completed Early Phase 1 study, sponsored by National University of Natural Medicine.
NCT02683850 is a Early Phase 1 study that has completed, run by National University of Natural Medicine. The registered enrollment target is 44 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (17% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02683850, a Early Phase 1 study, has completed, sponsored by National University of Natural Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
This prospective, non-randomized, open-label study will assess if taking an Omega-3 SPM™ soft gel supplement for four weeks will increase the quality of life in adults with chronic pain.
Primary Outcome
To assess the effect of 4 weeks of treatment with a SPM supplement on quality of life in a chronic pain population using the PROMIS-43 Profile (including PROMIS-43 subscales addressing physical function, fatigue, and sleep disturbance, ability to participate in social roles and activities).
Interventions
- DIETARY_SUPPLEMENT Omega-3 SPM™ softgel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-07 |
| Phase | Early Phase 1 |
What the finished NCT02683850 record still lists
NCT02683850 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (17% lower).
The record links to 0 conditions, and to 1 intervention - of which Omega-3 SPM™ softgel is the first listed.
NCT02683850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02683850 about?
NCT02683850 is a clinical study titled "Influence of an Omega-3 SPM Supplement on Quality of Life". This prospective, non-randomized, open-label study will assess if taking an Omega-3 SPM™ soft gel supplement for four weeks will increase the quality of life in adults with chronic pain.
What is the current status of trial NCT02683850?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 44 participants. The study started on 2016-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02683850?
The interventions under investigation include: Omega-3 SPM™ softgel (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02683850?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02683850's enrollment target sits among peer trials
44 589th of 2000 higher than 1,402 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia